The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Two targeted therapies, dabrafenib (taflinar) plus trametinib (mekinst), significantly increased the overall response rate compared to…
Based on guidance from biomarker screening, patients who are 55 years of age and older…
Immunotherapy has had limited success so far against glioblastoma, the most common and aggressive form…
Recent research led by MD Anderson identified associations between neoadjuvant immune checkpoint blockade responses and B…
Use of high-dose ifosfamide (Ifex) was found to be superior for treating recurrent and primary refractory…
The use of trastuzumab deruxtecan (Enhertu), a new HER2-targeting antibody-drug conjugate, doubled progression-free survival compared…
The use of panitumumab (Vectibix) plus mFOLFOX6 significantly improved overall survival in patients with RAS wild-type metastatic…
The use of autologous stem cell transplant (ASCT) early in the course of treatment showed…
Mount Sinai researchers have validated for the first time that a simple blood test called…
Many cancer treatments are notoriously savage on the body; they attack healthy cells at the…